Glutathione Therapy in Parkinson's Disease

Studies have proved glutathione to be very beneficial in Parkinson’s disease.

Glutathione is known to increase the sensitivity of the brain to dopamine. Therefore, even if glutathione does not increase the dopamine level, it makes its present level more effective. Besides this, glutathione being the body’s master antioxidant and detoxifier protects the brain from any damage caused by the free radicals, toxins and other chemicals.

The persons suffering from Parkinson’s disease are unable to detoxify the chemicals which enter their body.

Those persons who inherit a fault in their detoxification pathways are at a greater risk of suffering from brain damage caused by the toxins which enter the body.

Glutathione therapy is known to improve some of the Parkinson’s disease symptoms like difficulties with walking and other body movements, coordination and speech, less tremor, reduced depression, etc, to a great extent. Therefore, high glutathione levels can be of great help to the patients of Parkinson’s disease.

Intravenous glutathione therapy and intake of glutathione precursors are believed to be effective in boosting intracellular levels of glutathione.

However, oral intake of glutathione does not boost cellular glutathione levels efficiently as glutathione breaks down in the digestive tract before it finally reaches the cells.

MaxGXL helps to increase the glutathione levels in the body by helping the body cells to accelerate the glutathione production through a natural process.

MaxGXL is an amazing breakthrough. Dr John Nelson, the 159th president of the American Medical Association said of MaxGXL:
"This product, in my opinion, represents the single most important breakthrough in health that I will witness in my life time. I believe it will revolutionize, change, and transform the practice of medicine world-wide and make Dr Robert Keller (the formulator of MaxGXL) more famous than Jonas Salk who created the polio vaccine."